Richard Mularski to Janus Kinase Inhibitors
This is a "connection" page, showing publications Richard Mularski has written about Janus Kinase Inhibitors.
Connection Strength
0.047
-
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021 03 04; 384(9):795-807.
Score: 0.047